Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03745716 |
|---|---|
| Brief Title: | APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS) |
| First Submitted : | November 14, 2018 |
| First Submitted that Met QC Criteria : | November 16, 2018 |
| First Posted : | November 19, 2018 |
| Results First Submitted : | June 1, 2022 |
| Results First Posted with QC Comments : | June 23, 2022 |
| Results First Submitted that Met QC Criteria : | June 22, 2022 |
| Results First Posted : | July 12, 2022 |
| Last Update Submitted that Met QC Criteria : | June 22, 2022 |
| Last Update Posted : | July 12, 2022 |